Back

September 22, 2026 · Interviews

Interview: "The API Makes the Tool Interesting for My Own Workflows"

David, a developer and hobby investor, on using the StockMarketScan API and MCP next to the website, rate limits, and automating only research lists.

David, 37, developer and hobby investor. The interview was conducted in German and has been translated and lightly edited for length.

You don't only use stockmarketscan.com in the browser. What does your workflow look like?

I write small research tools to keep an eye on the market for myself, so the API was the part that caught my attention. There are documented endpoints for screeners, chart patterns, market data and options data, plus an MCP connection for AI clients. That means the data ends up in my own setup and I'm not stuck with the dashboard alone.

What exactly do you do with it?

I pull the screener metadata on a schedule and save selected hits to a local overview. I can also ask for detected chart patterns on specific symbols. It saves me a lot of repetitive clicking, and I get to decide how things are displayed. For example, I merge hits from different lists and sort them by my own criteria.

What role does the website still play?

A big one. The API gives me structured data, but when I want to actually look at a stock I open stockmarketscan.com and check the chart and the screener context. I don't want to work from tables only. The site and the API cover different parts of the job for me.

What do you like about the API?

The docs are well organized: authentication via a header, JSON responses, every parameter described, rate limits stated. The data comes from the same source as the dashboard, so what I see in my scripts matches what I see in the browser. It's also clear which endpoints are public and which features need a particular plan.

How do you deal with the rate limits?

I plan my requests and cache the results so I'm not fetching the same data over and over. For a personal workflow that's usually plenty. If a script updates an overview once a day, there's not much to it. If you want to poll more often, you have to stick to what the documentation says and can't assume unlimited access.

Do you also use the AI connection?

Yes, within limits I set myself. I let an AI client pull a screener list or summarize hits by certain criteria, which speeds up the research. I don't allow it to execute orders, and I check anything important myself. It can help me organize data or phrase questions. It doesn't get to make investment decisions nobody has checked.

Can you give an example of such an analysis?

Say I want the overlap between a momentum screener and a technical screener. I get the shared symbols, sorted by volume or chart pattern, and then check them by hand on stockmarketscan.com. The list is shorter and I didn't have to compare two tables manually to get it.

Isn't that more something for professional users?

The API is aimed at more advanced users, sure. If you only look for stocks now and then, you probably don't need it. For me it's a big plus because I can plug the screeners into my own process. And people who don't program can use stockmarketscan.com through the normal interface, which I think is good.

Are there limits to your automated workflow?

Of course. Data changes, a screener can return different hits tomorrow, and a chart pattern doesn't guarantee a price move. So my scripts only build research lists. They don't place orders, don't touch any accounts and don't replace checking the original sources. That matters to me, because automation can give you a false sense of security very quickly.

Your overall verdict?

I like stockmarketscan.com a lot because it works for a quick start and for more technical setups. The ready-made screeners give me ideas, the charts let me check them, and the API automates the research part. I could start small and move individual pieces into my own workflow later, without building a whole piece of software first.

Related Resources

This interview reflects one user's personal experience. It is not investment advice, and screener results are research data, not recommendations.